These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7875022)

  • 1. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of DQ-2556, a new cephalosporin.
    Fujimoto T; Otani T; Nakajima R; Une T; Osada Y
    Antimicrob Agents Chemother; 1986 Oct; 30(4):611-3. PubMed ID: 3539013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of DQ-2556 and its mode of action.
    Tanaka M; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.
    Hafeez S; Izhar M; Ahmed A; Zafar A; Naeem M
    J Pak Med Assoc; 2000 Aug; 50(8):250-2. PubMed ID: 10992706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study].
    Soussy CJ; Chanal M; Derlot E; Goldstein F; Duval J
    Pathol Biol (Paris); 1994 Oct; 42(8):754-60. PubMed ID: 7724247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial properties of Ro 13-99041, a long-acting new cephalosporin.
    Angehrn P; Probst PJ
    Chemotherapy; 1981; 27 Suppl 1():9-14. PubMed ID: 7249797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.
    Toyosawa T; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
    Antimicrob Agents Chemother; 1993 Jan; 37(1):60-6. PubMed ID: 8431019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Klebsiella spp. to cefpirome and cefepime.
    Tuchiluş C; Poiată A; Iancu LS; Bădicuţ I; Ambăruş A; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):465-7. PubMed ID: 17802963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
    Arsalan A; Naqvi SB; Ali SA; Ahmed S; Shakeel O
    Pak J Pharm Sci; 2015 May; 28(3):841-7. PubMed ID: 26004702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
    Neu HC; Aswapokee N; Aswapokee P; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
    Tumah H
    Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
    Chantot JF; Bryskier A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):482-6. PubMed ID: 3937124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefpirome (HR 810). A new broad spectrum cephalosporin].
    Bryskier A; Chantot JF
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):477-81. PubMed ID: 3937123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of new antibiotics against bacterial isolates from a community hospital.
    Dyke JW; Angones D; Bhakta D; Tenjarla G; Kumar A
    Chemotherapy; 1993; 39(5):315-21. PubMed ID: 8370322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.